Skip to content
Home
About us
Careers
Investors
Corporate governance
Shareholder information
Investor tools
Directors' shareholdings
SEC filings
Events calendar
Financial results
Annual reports
Presentations & webcasts
-
2008
-
2007
-
2006
-
2005
-
2004
-
2003
-
2002
-
2001
-
2000
-
1999
Financial highlights
Strategy
FAQs
Investor contacts
Media
Partnering
Products
Research
Responsibility
Contact us
Home
Investors
Presentations & webcasts
2000
2000 Presentations
2000 full year results presentation (8 February 2001)
Presentation slides - 75 kb
2000 AstraZeneca R&D update and site visit, AstraZeneca Mölndal, Sweden
(12 December 2000)
Press release - 27 kb
Discovery - Jan M Lundberg - 3,900 kb
Cardiovascular - Hamish Cameron - 1,700 kb
Gastrointestinal - part 1 - Hans Glise - 145 kb
Gastrointestinal - part 2 - Martin Nicklasson - 273 kb
Therapy area update - Claes Wilhelmsson - 1,180 kb
AstraZeneca websites
Search
Advanced search
Quick links
Key products
R&D pipeline
Visit Dow Jones (external link)
Visit FTSE4Good (external link)
Site map
Order a report
Online order form
Tel: +44 (0)1707 256 677
Share price
London
22.25
GBP
New York
43.56
USD
Stockholm
260.50
SEK
Updated 11:13 GMT 17 May 08
Downloads
Acrobat® PDF Reader (external link)
Terms of use
Privacy policy
© AstraZeneca PLC 2003 - 2008